 Mutation
"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 17 | 22 | | 1997 | 7 | 21 | 28 | | 1998 | 16 | 20 | 36 | | 1999 | 3 | 25 | 28 | | 2000 | 9 | 34 | 43 | | 2001 | 7 | 44 | 51 | | 2002 | 15 | 40 | 55 | | 2003 | 12 | 58 | 70 | | 2004 | 11 | 53 | 64 | | 2005 | 8 | 63 | 71 | | 2006 | 13 | 66 | 79 | | 2007 | 31 | 54 | 85 | | 2008 | 30 | 64 | 94 | | 2009 | 19 | 66 | 85 | | 2010 | 22 | 71 | 93 | | 2011 | 26 | 70 | 96 | | 2012 | 38 | 72 | 110 | | 2013 | 36 | 90 | 126 | | 2014 | 40 | 98 | 138 | | 2015 | 55 | 84 | 139 | | 2016 | 45 | 119 | 164 | | 2017 | 34 | 120 | 154 | | 2018 | 50 | 109 | 159 | | 2019 | 46 | 116 | 162 | | 2020 | 32 | 96 | 128 | | 2021 | 27 | 118 | 145 | | 2022 | 4 | 127 | 131 | | 2023 | 1 | 94 | 95 | | 2024 | 27 | 63 | 90 | | 2025 | 29 | 79 | 108 | | 2026 | 12 | 36 | 48 |
To return to the timeline, click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Teklemariam TA, Finnerty RM, Coats JB, Nelson SW. Basic-patch mutations in bacteriophage T4 Rad50 uncouple ATPase activation from processive nuclease activity. Biosci Rep. 2026 Aug 19; 46(8).
-
Shulman DS, Vo KT, Balis FM, Lindsay H, DeNardo BD, Place AE, Chi SN, Kamihara J, O'Neill AF, Church AJ, Crompton BD, Klega K, Tanhaemami M, Armant M, Pikman Y, Stegmaier K, Ezrre S, Czaplinski J, Walensky LD, Annis DA, Bhushan K, Kao PC, London WB, DuBois SG. A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies. Clin Cancer Res. 2026 Aug 14; 32(16):3466-3475.
-
Srinivasan S, Eraghi MM, Odiase P, Mazumder S, Ahuja A, Ranganathan S, Patel P, O'Leary S, Guirguis M, Barrie U, Sun MZ, Patel A. Prognostic utility of tumor grade and IDH-mutation status for immunotherapy response in high grade glioma: a systematic review and meta-analysis. J Clin Neurosci. 2026 Oct; 152:112202.
-
Pastrana CC, Nonavinkere Srivatsan S, Alberti MO, Hossan T, Ahmed T, Shao J, Chavez M, Grieb S, Padro JI, Paul DM, George DR, Patil A, Rai S, Graubert TA, Bailis JM, You Z, Walter MJ. Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage. Cancer Res. 2026 07 15; 86(14):3537-3553.
-
Schafer JB, Malcolm KC, Dell-Martin J, Amaya ML, Pollyea DA, Alper S. Weakened macrophage antibacterial capacity in myelodysplastic syndrome. Immunohorizons. 2026 Jul 10; 10(7).
-
Richbourg H, Rangel Miller V, Khazaie Japalaghi O, AlSayed M, Baker PR, Daugherty S, Ekstein T, Grünert SC, Kiel MJ, Khan A, Kobayashi H, Korngut L, Monteleone SA, Schwartz IVD, Miller N, Vockley J. Long-Chain Fatty Acid Oxidation Disorder Genes: A Comprehensive Genetic Database of LC-FAOD Variants, Genotypes, and Phenotypes. Hum Mutat. 2026; 2026:6864813.
-
Hoff FW, Zeidner JF, Torlapati G, Nicolet D, Mrózek K, Huang Y, Li A, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Olin RL, Smith CC, Schiller GJ, Curran EK, Chan O, McMahon C, Hochman M, Sahasrabudhe K, Foucar C, Gonzalez-Lugo J, Knick Ragon B, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Eisfeld AK, Byrd JC, Madanat YF. Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA. Am J Hematol. 2026 Sep; 101(9):2246-2257.
-
Hénault M, Wood LM, Heasley LR. Towards a unified model of aneuploid karyotype dynamics. PLoS Genet. 2026 Jun; 22(6):e1012210.
-
Lovly CM, Baik C, Nagasaka M, Patil T, Maruti SS, Stanhope S, Kaya NA, Herbertz S, Nordstrom B, Evans K, Le X. Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer. JCO Precis Oncol. 2026 Jun; 10(6):e2501272.
-
Mumme-Monheit A, Mitchell JM, Bailon-Zambrano R, Wright N, Neukirch LA, Keating MK, Hopkins CA, Riemondy K, Gustafson GE, Moss ND, Medeiros DM, Nichols JT. The alx gene family confers segmental identity to frontonasal cranial neural crest cells. Nat Commun. 2026 06 18; 17(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|